The largest database of trusted experimental protocols

Slide angiogenesis chamber

Manufactured by Ibidi
Sourced in Germany

The µ-slide angiogenesis chambers are specialized lab equipment designed for the study of angiogenesis, the process of new blood vessel formation. The chambers provide a controlled environment for the cultivation and observation of cells, tissues, or other biological samples during angiogenic processes.

Automatically generated - may contain errors

5 protocols using slide angiogenesis chamber

1

Matrigel-based Endothelial Cell Tube Formation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Matrigel (basement membrane matrix, growth factor reduced, BD Biosciences; Bedford, Mass.) was filled into µ-slide angiogenesis chambers (ibidi; Martinsried, Germany) and was polymerized for 30 minutes at 37°C. HUVECs were seeded onto the Matrigel and were incubated with different concentrations of BoNT mixed with the EGM-2 (Lonza; Basel, Switzerland) containing vascular endothelial growth factor (VEGF). After 6 hours of incubation, the cells were photographed with an inverted Nikon Eclipse Ti-E microscope (Nikon; Tokyo, Japan), and the number of tubes, the total tube length, the number of loops and branching points, and the covered area in percent were calculated by Wimasis (Wimasis GmbH; Munich, Germany).
+ Open protocol
+ Expand
2

Angiogenic Potential of Adipose-Derived Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wells of µ-Slide Angiogenesis chambers (Ibidi, Martine Marne, Germany) were coated with a 0.8 mm thick layer of gel matrix by adding 10 µL of Cultrex Reduced Growth Factor Basement Membrane Matrix. After gel polymerization, 5000 HUVECs were seeded in M199 added with 5% FCS and treated with conditioned medium of undifferentiated or differentiated ADSCs. Cell viability was confirmed using calcein-AM. In live cells, the non-fluorescent calcein-AM is converted into green-fluorescent calcein. Calcein-AM is a permeant dye. After 5 h, samples were photographed using an inverted Axiovert 200 M epifluorescence microscope equipped with an LD A PLAN 20X/0,30PH1 objective (Carl Zeiss, Oberkochen, Germany). Images were analyzed using ImageJ software with the Angiogenesis plugin to detect total closed structures [24 (link)].
+ Open protocol
+ Expand
3

Angiogenesis Tube Formation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
In total, 2 × 103 BECs were seeded in µ-slide angiogenesis chambers (Ibidi, Munich, Germany) on growth factor-reduced matrigel (BD Biosciences, San Jose, CA, USA). Cells were supplemented with 0, 10, 100 or 1000 ng/ml of recombinant CCL20 (R&D Systems) in EGM-2MV containing 5% FCS (Clonetics). Tube formation was imaged with a Zeiss Cell Observer (Zeiss).
+ Open protocol
+ Expand
4

Invading Cancer Cells in 3D Gels

Check if the same lab product or an alternative is used in the 5 most similar protocols
The interplay of CAFs and AsPC-I during infiltration of the surrounding matrix was studied with heterospheroids embedded in 3D gels made of ECM components. The iCAF and α3KO-iCAFs were transduced with lentivirus containing a mCherry vector, and AsPC-I and PANC-I cells with a lentivirus containing a GFP vector. Both vectors were kindly provided by Dr. Stephan Huveneers. The transduction was performed as detailed in Section 4.2, and the virus was produced as described in Section 4.9 and concentrated using the kit Lenti-X™ Concentrator (Takara Bio Inc., Shiga, Japan). The transfected iCAFs, AsPC-I and PANC-I cells were selected with puromycin (see Section 4.9). Being already resistant to puromycin, α3KO-iCAFs were sorted by fluorescence-assisted cell sorting. The heterospheroids comprised 400 mCherry-iCAFs or mCherry-α3KO-iCAFs as well as 400 GFP-AsPC-I or GFP-PANC-I cells. The homospheroids also comprised 400 of each cell type. The spheroids were embedded into a gel composed of 2 mg/mL of rat tail collagen I, 30% Matrigel (Thermo Fisher Scientific) and 2.5 µg/mL of laminin-332, on a µ-Slide angiogenesis chamber (Ibidi, Martinsried, Germany). The gel was overlaid with cell culture medium and images were acquired using the confocal microscope (LSM 800, Zeiss). The experiment was analysed for the number of invading AsPC-I cancer cells (Figure 6D).
+ Open protocol
+ Expand
5

Endothelial Cell Spheroid Sprouting Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human umbilical vein endothelial cells (HUVEC) were cultured in the Endothelial Growth Medium-2 (EGM-2, Lonza), and cells in the passage 2–5 were used in this study. Some of the experiments were performed with HUVECs stably transduced with LifeAct-Green Fluorescent Protein (GFP). Spheroids (500 cells per spheroid) were formed with the use of an AggreWell 400 device (STEMCELL Technologies, Vancouver, Canada) according to the manufacturer’s instructions. After a 24 h incubation, the spheroids were harvested and embedded in the growth factor-reduced Matrigel (Corning, New York, NY, USA) within a µ-Slide Angiogenesis chamber (Ibidi, Gräfelfing, Germany). EGM-2 medium containing microparticles was added to the samples after Matrigel gelation. Endothelial cell sprouting was monitored for up to 3 days. Alternatively, single cell HUVECs were seeded on top of the Matrigel and the effect of microparticles on capillary network formation in 2D was evaluated after 24 h. Image analysis was performed using ImageJ and the Sprout Morphology plugin [24 (link)]. We estimated the sprouting features including sprout number, length, and density of endothelial cells grown in a bead sprouting assay. Formation of cellular capillary-like networks was evaluated with the Angiogenesis Analyzer ImageJ plugin [25 ].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!